Proactive and Reactive Attention to Negative Templates

October 4, 2023 updated by: Lehigh University
EEG Measures during Visual Search Task. In this line of research, the researchers having participants receive a positive (target) template cue, negative (distractor) template cue, or neutral (non-informative) template cue. Note: This is a re-analysis of previously collected data.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

When finding a search target, receiving a target cue or distractor cue can increase search efficiency compared to a neutral cue. The researchers are examining the neural basis of visual search when participants receive a positive (target) cue, negative (distractor) cue, or neutral (baseline) cue. Note: This is a re-analysis of previously collected data.

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Bethlehem, Pennsylvania, United States, 18015
        • Lehigh University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • normal or corrected to normal visual acuity, normal color vision, no history of neurological disorders

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Within-Subjects Attentional Information
All Participants receive all levels of the attentional cue (target, distractor, or neutral cue).
Positive cue (target), negative cue (distractor), or neutral cue (baseline)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Button Press Reaction Time
Time Frame: During Testing (single day)
Speed to respond correctly to the target- after participant finds the target shape on a computer screen, they press a button to indicate what shape they see
During Testing (single day)
Button Press Accuracy
Time Frame: During Testing (single day)
Accuracy of responses to target item- we will measure whether the participants presses the correct button which corresponds to the target shape presented on the computer screen or the incorrect button
During Testing (single day)
Proactive EEG Activity
Time Frame: During Testing (single day)
Proactive (pre-search) Measures of EEG Theta Activity
During Testing (single day)
Reactive EEG Activity
Time Frame: During Testing (single day)
Reactive (post-search) Measures of EEG Alpha Activity
During Testing (single day)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nancy Carlisle, PhD, Lehigh University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 11, 2014

Primary Completion (Actual)

April 2, 2015

Study Completion (Actual)

April 2, 2015

Study Registration Dates

First Submitted

May 31, 2023

First Submitted That Met QC Criteria

October 4, 2023

First Posted (Actual)

October 5, 2023

Study Record Updates

Last Update Posted (Actual)

October 5, 2023

Last Update Submitted That Met QC Criteria

October 4, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 8R15EY030247-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We plan to share anonymized subject data on Open Science Framework.

IPD Sharing Time Frame

Upon publication.

IPD Sharing Access Criteria

Open Science Framework internet access.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe